These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 7567787)

  • 1. Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.
    Kairiyama C; Slavutsky I; Larripa I; Morvillo V; Bravo AI; Bover L; Podhajcer OL; Mordoh J
    Pigment Cell Res; 1995 Jun; 8(3):121-31. PubMed ID: 7567787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases.
    Morvillo V; Lüthy IA; Bravo AI; Capurro MI; Portela P; Calandra RS; Mordoh J
    Melanoma Res; 2002 Dec; 12(6):529-38. PubMed ID: 12459642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
    Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
    Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses.
    Emoto M; Iwasaki H; Kikuchi M; Ishiguro M; Kubota T; Izumi H; Shirakawa K; Kaneko Y
    Cancer; 1992 Apr; 69(7):1759-68. PubMed ID: 1312893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of IIB-MEL-J: a new and highly heterogenous human melanoma cell line.
    Guerra L; Mordoh J; Slavutsky I; Larripa I; Medrano EE
    Pigment Cell Res; 1989; 2(6):504-9. PubMed ID: 2602342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.
    Van Muijen GN; Cornelissen LM; Jansen CF; Figdor CG; Johnson JP; Bröcker EB; Ruiter DJ
    Clin Exp Metastasis; 1991; 9(3):259-72. PubMed ID: 2060184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to prove the melanoma origin in amelanotic human melanoma cell lines.
    Blasko M; Chalupa I; Borovanský J; Toceková M; Siracký J
    Neoplasma; 1996; 43(6):411-5. PubMed ID: 8996567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
    Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi.
    Podhajcer OL; Bover L; Bravo AI; Ledda MF; Kairiyama C; Calb I; Guerra L; Capony F; Mordoh J
    J Invest Dermatol; 1995 Mar; 104(3):340-4. PubMed ID: 7860998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.
    Ledda F; Bravo AI; Adris S; Bover L; Mordoh J; Podhajcer OL
    J Invest Dermatol; 1997 Feb; 108(2):210-4. PubMed ID: 9008236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
    Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
    Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.
    Morvillo V; Bover L; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):779-95. PubMed ID: 8832109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.
    Heim S; Mandahl N; Arheden K; Giovanella BC; Yim SO; Stehlin JS; Mitelman F
    Cancer Genet Cytogenet; 1988 Oct; 35(1):5-20. PubMed ID: 3180009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization.
    Nishio J; Iwasaki H; Nabeshima K; Ishiguro M; Naumann S; Isayama T; Naito M; Kaneko Y; Kikuchi M; Bridge JA
    Int J Oncol; 2005 Aug; 27(2):361-9. PubMed ID: 16010416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
    Shimizu Y; Demetris AJ; Gollin SM; Storto PD; Bedford HM; Altarac S; Iwatsuki S; Herberman RB; Whiteside TL
    Int J Cancer; 1992 Sep; 52(2):252-60. PubMed ID: 1355757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
    Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
    Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.
    Lehmann F; Marchand M; Hainaut P; Pouillart P; Sastre X; Ikeda H; Boon T; Coulie PG
    Eur J Immunol; 1995 Feb; 25(2):340-7. PubMed ID: 7875194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of human vaginal malignant melanoma xenotransplants.
    Sawada M; Terada N; Nishizawa Y; Ito S; Wakamatsu K; Takemura K; Yamamoto T; Ozaki M; Sakamoto H; Tanizawa O
    Anticancer Res; 1994; 14(4A):1477-82. PubMed ID: 7526770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.